Building Stakeholder Engagement Through EAPs

BUILDING STAKEHOLDER ENGAGEMENT THROUGH EAPs Download our guide on leveraging Early Access Programs to engage healthcare professionals, payers, and empower eligible patients with early access to innovative therapies. Gain valuable insights, contribute to real-world [...]

By |2024-03-26T15:08:55+00:00March 4th, 2024|

International Recognition Procedure

International Recognition Procedure From January 2024, the MHRA is adopting the International Recognition Procedure, reflecting a strategic pivot towards an independent and collaborative regulatory framework for swift and secure drug authorizations in the UK. Our [...]

By |2024-03-07T13:34:51+00:00December 19th, 2023|

EU Health Technology Assessments

Navigating the Future of EU Joint Health Technology Assessments With the Health Technology Assessment (HTA) landscape undergoing transformation in January 2025, it's essential to prepare your pipeline for what lies ahead. Our Market Access [...]

By |2024-03-26T15:18:21+00:00November 2nd, 2023|

Value of Real World Data in EAP

COLLECTING REAL WORLD DATA IN EAPs We recognize the tremendous value Real World Data (RWD) can offer in the pre-approval space and work closely with our Sponsors to understand the opportunity for RWD collection [...]

By |2024-03-26T16:06:35+00:00July 21st, 2022|

PA-NPP Product Uptake By Country

Product Uptake By Country PA-NPPs adhere to strict legislation regarding the supply of unlicensed medicines on an unsolicited request basis. As such, there are many factors that determine the level of uptake in a [...]

By |2024-03-26T15:06:22+00:00November 25th, 2021|

EAP Versus OLE Study

EAP VERSUS OLE Both an Open Label Extension (OLE) and an Expanded Access Program (EAP) can be used to provide continued treatment access after phase 3 clinical trials have ended. To help companies understand [...]

By |2024-03-26T16:10:14+00:00January 20th, 2021|

Sponsor Considerations for EAPs

SPONSOR CONSIDERATIONS FOR EAPs If your company is developing a drug that fulfils an unmet clinical need, you may have already started receiving patient enquiries about expanded access. We have put together this downloadable [...]

By |2024-03-26T16:12:30+00:00December 11th, 2020|
Page 1 of 2
1 2
Go to Top